Protein expression profiling of lens epithelial cells from Prdx6-depleted mice and their vulnerability to UV radiation exposure

Am J Physiol Cell Physiol. 2010 Feb;298(2):C342-54. doi: 10.1152/ajpcell.00336.2009. Epub 2009 Nov 4.

Abstract

Oxidative stress is one of the causative factors in progression and etiology of age-related cataract. Peroxiredoxin 6 (Prdx6), a savior for cells from internal or external environmental stresses, plays a role in cellular signaling by detoxifying reactive oxygen species (ROS) and thereby controlling gene regulation. Using targeted inactivation of the Prdx6 gene, we show that Prdx6-deficient lens epithelial cells (LECs) are more vulnerable to UV-triggered cell death, a major cause of skin disorders including cataractogenesis, and these cells display abnormal protein profiles. PRDX6-depleted LECs showed phenotypic changes and formed lentoid body, a characteristic of terminal cell differentiation and epithelial-mesenchymal transition. Prdx6(-/-) LECs exposed to UV-B showed higher ROS expression and were prone to apoptosis compared with wild-type LECs, underscoring a protective role for Prdx6. Comparative proteomic analysis using fluorescence-based difference gel electrophoresis along with mass spectrometry and database searching revealed a total of 13 proteins that were differentially expressed in Prdx6(-/-) cells. Six proteins were upregulated, whereas expression of seven proteins was decreased compared with Prdx6(+/+) LECs. Among the cytoskeleton-associated proteins that were highly expressed in Prdx6-deficient LECs was tropomyosin (Tm)2beta. Protein blot and real-time PCR validated dramatic increase of Tm2beta and Tm1alpha expression in these cells. Importantly, Prdx6(+/+) LECs showed a similar pattern of Tm2beta protein expression after transforming growth factor (TGF)-beta or H(2)O(2) treatment. An extrinsic supply of PRDX6 could restore Tm2beta expression, demonstrating that PRDX6 may attenuate adverse signaling in cells and thereby maintain cellular homeostasis. Exploring redox-proteomics (Prdx6(-/-)) and characterization and identification of abnormally expressed proteins and their attenuation by PRDX6 delivery should provide a basis for development of novel therapeutic interventions to postpone ROS-mediated abnormal signaling deleterious to cells or tissues.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apoptosis / radiation effects
  • Blotting, Western
  • Cells, Cultured
  • Cytoprotection*
  • Dose-Response Relationship, Radiation
  • Electrophoresis, Gel, Two-Dimensional
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • Epithelial Cells / pathology
  • Epithelial Cells / radiation effects*
  • Eye Proteins / genetics
  • Eye Proteins / metabolism*
  • Gene Expression Regulation / radiation effects
  • Hydrogen Peroxide / toxicity
  • Lens, Crystalline / drug effects
  • Lens, Crystalline / metabolism
  • Lens, Crystalline / pathology
  • Lens, Crystalline / radiation effects*
  • Mice
  • Mice, Knockout
  • Oxidation-Reduction
  • Oxidative Stress / radiation effects
  • Peptide Mapping
  • Peroxiredoxin VI / deficiency*
  • Peroxiredoxin VI / genetics
  • Peroxiredoxin VI / metabolism
  • Phenotype
  • Proteomics / methods*
  • RNA, Messenger / metabolism
  • Reactive Oxygen Species / metabolism
  • Recombinant Fusion Proteins / metabolism
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Tropomyosin / metabolism
  • Ultraviolet Rays*

Substances

  • Eye Proteins
  • RNA, Messenger
  • Reactive Oxygen Species
  • Recombinant Fusion Proteins
  • Tpm1 protein, mouse
  • Tropomyosin
  • Hydrogen Peroxide
  • PRDX6 protein, human
  • Peroxiredoxin VI
  • Prdx6 protein, mouse